Increased Uptake of 68Ga-DOTA-IBA in Polymorphous Adenocarcinoma of the Parotid Gland

Key Points

• To evaluate the effectiveness of 68Ga-DOTA-IBA in identifying bone metastases and primary tumors in polymorphous adenocarcinoma.
• Conducted a PET/CT scan using 68Ga-labeled DOTA-IBA.
• Assessed uptake in multiple bone metastases.
• Monitored uptake in the primary parotid tumor.
• Increased 68Ga-DOTA-IBA uptake was found in multiple bone metastases.
• Unexpected uptake was also observed in the primary parotid polymorphous adenocarcinoma.